U.K. multicentre study on blood donors for surrogate markers of non‐A non‐B hepatitis. Part I: Alanine transferase and anti‐HBc testing

Publisher Website
Google Scholar
Abstract
SUMMARY. Blood samples from 9,215 blood donors in three U.K. centres (North London, Bristol and Manchester) were tested for their alanine aminotransferase (ALT) level and the presence of anti‐HBc and anti‐HCV. This paper presents the results of the ALT and anti‐HBc tests. The prevalence of ALT >45 IU/1 was 3.1% overall (North London 3.06%, Bristol 4.56% and Manchester 1.97%). Manchester results were skewed by the methodology used for ALT measurement, highlighting the need for standard test methods. Anti‐HBc was detected using the Wellcome enzymeimmunosorbent assay (EIA) and confirmatory testing was performed using a radioimmunoassay (RIA) and the Corecell haemagglutination assay. Repeat reactive rates were 0.9, 0.79 and 0.94% for North London, Bristol and Manchester, respectively, with an overall rate of 0.9%. The confirmed positive rate was 0.73, 0.53 and 0.65% for the three centres with an overall rate of 0.63%. Donors with an ALT >45 IU/1, or with confirmed anti‐HBc, were interviewed with a medical questionnaire for risk factors. The major contributing factors in donors with a raised ALT were alcohol consumption and obesity.